Literature DB >> 12936985

Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.

Mark A Toleman1, Kenneth Rolston, Ronald N Jones, Timothy R Walsh.   

Abstract

As part of the CANCER Antimicrobial Surveillance Program in North America, a clinical strain of Pseudomonas aeruginosa, strain 07-406, isolated in Texas was found to be resistant to all antimicrobials except polymyxin B. Genetic analysis of this isolate identified two unique extended-spectrum beta-lactamase genes. One, bla(VIM-7), encoded a metallo-beta-lactamase (unpublished data), and the other, bla(OXA-45), described here, encoded a class D extended-spectrum beta-lactamase. bla(OXA-45) was isolated on a Sau3A1 genomic fragment of 1.8 kb and encodes a protein of 264 amino acids with the highest identities to OXA-18 (65.9%), OXA-9 (42.8%), OXA-22 (40.2%), OXA-12 (38.6%), and OXA-29 (35.2%) but weak identities with other class D beta-lactamases. bla(OXA-45) was found to be harbored on a 24-kb plasmid in a region that displays high identities with a section of the 43-kb genomic island of Salmonella enterica serovar Typhimurium DT104. Biochemically OXA-45 is most similar to OXA-18 in its substrate profile and inhibition by clavulanic acid and is a member of the 2d' class of beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12936985      PMCID: PMC182593          DOI: 10.1128/AAC.47.9.2859-2863.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Crystal structure of the class D beta-lactamase OXA-10.

Authors:  M Paetzel; F Danel; L de Castro; S C Mosimann; M G Page; N C Strynadka
Journal:  Nat Struct Biol       Date:  2000-10

3.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 4.  OXA-type beta-lactamases.

Authors:  T Naas; P Nordmann
Journal:  Curr Pharm Des       Date:  1999-11       Impact factor: 3.116

Review 5.  Carbapenemases: a problem in waiting?

Authors:  D M Livermore; N Woodford
Journal:  Curr Opin Microbiol       Date:  2000-10       Impact factor: 7.934

6.  Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.

Authors:  L Pernot; F Frénois; T Rybkine; G L'Hermite; S Petrella; J Delettré; V Jarlier; E Collatz; W Sougakoff
Journal:  J Mol Biol       Date:  2001-07-20       Impact factor: 5.469

7.  Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona.

Authors:  D Boyd; G A Peters; A Cloeckaert; K S Boumedine; E Chaslus-Dancla; H Imberechts; M R Mulvey
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

8.  Insights into class D beta-lactamases are revealed by the crystal structure of the OXA10 enzyme from Pseudomonas aeruginosa.

Authors:  L Maveyraud; D Golemi; L P Kotra; S Tranier; S Vakulenko; S Mobashery; J P Samama
Journal:  Structure       Date:  2000-12-15       Impact factor: 5.006

9.  OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Authors:  L N Philippon; T Naas; A T Bouthors; V Barakett; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

10.  Nucleotide and amino acid sequences of the metallo-beta-lactamase, ImiS, from Aeromonas veronii bv. sobria.

Authors:  T R Walsh; W A Neville; M H Haran; D Tolson; D J Payne; J H Bateson; A P MacGowan; P M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

View more
  21 in total

1.  Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.

Authors:  Mariana Castanheira; Mark A Toleman; Ronald N Jones; Franz J Schmidt; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 2.  ISCR elements: novel gene-capturing systems of the 21st century?

Authors:  Mark A Toleman; Peter M Bennett; Timothy R Walsh
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

3.  blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.

Authors:  H Aboufaycal; H S Sader; K Rolston; L M Deshpande; M Toleman; G Bodey; I Raad; R N Jones
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

Review 4.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

5.  Molecular analysis of the sequences surrounding blaOXA-45 reveals acquisition of this gene by Pseudomonas aeruginosa via a novel ISCR element, ISCR5.

Authors:  Hongyang Li; Timothy R Walsh; Mark A Toleman
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

Review 6.  Class D β-lactamases: a reappraisal after five decades.

Authors:  David A Leonard; Robert A Bonomo; Rachel A Powers
Journal:  Acc Chem Res       Date:  2013-07-31       Impact factor: 22.384

7.  OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins.

Authors:  Laurent Poirel; Mariana Castanheira; Amélie Carrër; Carla Parada Rodriguez; Ronald N Jones; Jorgelina Smayevsky; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

8.  Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.

Authors:  Ellen S Moland; Nancy D Hanson; Jennifer A Black; Ashfaque Hossain; Wonkeun Song; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

9.  Genetic structure associated with blaOXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase.

Authors:  Thierry Naas; Fatemeh Namdari; Pierre Bogaerts; Te-Din Huang; Youri Glupczynski; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

10.  Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources.

Authors:  Fitzroy A Orrett
Journal:  J Natl Med Assoc       Date:  2004-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.